Eduard Gratacós
Eduard Gratacós Solsona is a scientist and physician specializing in obstetrics and gynecology and an expert in maternal-fetal medicine and fetal surgery. Gratacós was one of the pioneers of the concept of the fetus as a patient and has published monographic treatises on fetal medicine. He is currently the lead in the Spanish artificial placenta project.
Professional and academic background
After training as a specialist at the Hospital Clínic de Barcelona, between 1997 and 2000 he worked in Leuven as a post-doctorate researcher and subsequently took over the management of the Fetal Medicine Unit. At Leuven, he worked under Jan Deprest and joined the Eurofoetus group, which pioneered fetal surgery in Spain. He performed the first-ever fetal surgery in Spain in 1999 at the Vall d'Hebron University Hospital of Barcelona.The following year, in 2000, he created the first fetal surgery and medicine unit in Spain. In 2005, he joined the Hospital Clínic as Head of the Department of Maternal and Fetal Medicine. Several years later, in 2013, he spearheaded the creation of BCNatal, a Maternal and Fetal and Neonatal Medicine Center of the Hospital Clínic and Hospital Sant Joan de Déu of Barcelona, one of the leading clinical and research centers in fetal medicine and surgery in Europe, which he currently manages.
He is also a Professor of the Universitat de Barcelona. He is the director of the Fetal Medicine research groups at IDIBAPS, at the Institut de Recerca Sant Joan de Déu and at CIBERER.
Research
His main lines of research have been placental insufficiency, fetal programming and fetal surgery. He has authored more than 600 scientific articles. He has been principal investigator in more than 60 national and international projects and Director of the PhD Program in Perinatal Medicine of the European Commission. He has supervised more than 40 PhD theses. The main scientific contributions of his research group feature the description of a fetal growth restriction staging system, the description of a selective fetal growth restriction classification system in monochorionic pregnancy, and the demonstration that several fetal conditions lead to fetal programming at neurological and cardiovascular level, as well as the development and first application of new fetal surgery techniques in the world, tracheal occlusion for diaphragmatic hernia and the first fetal surgeries for fetal airway obstruction. More recently, his research group has demonstrated that maternal lifestyle interventions reduce the complications of pregnancy and improve fetal neurodevelopment. He has also promoted the La Caixa Research Placenta Artificial Project, one of the few artificial placenta experimental projects in the world.He is a co-inventor of 5 patents. Now, in December 2023, he has an h-index of 105.